Prudential Financial’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Buy
+45,354
New +$263K ﹤0.01% 2230
2024
Q3
– Sell
-784
Closed -$6.86K – 2709
2024
Q2
$6.86K Buy
+784
New +$13.8K ﹤0.01% 2680

Other funds holding ALGS

Prudential Financial's ALGS Position: Q3 2026 in Review

Prudential Financial opened a new position in Aligos Therapeutics (ALGS) in Q3 2026: 45,354 shares worth $255K. The stake represents ﹤0.01% of the portfolio and ranks #2230 among its holdings. This is a return to the name: Prudential Financial previously reported a position in ALGS as recently as Q2 2024.

Prudential Financial first reported a position in ALGS in Q2 2024 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold ALGS as of Q3 2026.

  • Prudential Financial held 45,354 shares of Aligos Therapeutics worth $255K as of Q3 2026.
  • Aligos Therapeutics was a new Prudential Financial position in Q3 2026.
  • Aligos Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q3 2026, its #2230 holding.
  • Prudential Financial first reported a position in Aligos Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q3 2026.

Based on Prudential Financial's 13F filing for Q3 2026, filed 16 Nov 2026.